EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Epigenetics in Corneal Fibrosis

Julia T Coelho iD, Ella J Dewald, Syeda R Ali, Moira L Geary iD, Mithun Santra iD, Gary H F Yam

Epigenomes · 06.06.2026 · 10 (2) · 40

DOI: 10.3390/epigenomes10020040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epigenomes, online erschienen am 06.06.2026. Verfasst von Julia T Coelho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15219, USA. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Research to Prevent Blindness, Hillman Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetics regulates gene activity without altering the underlying DNA sequences. Numerous studies have highlighted the importance of epigenetics in diverse physiological processes, including cell growth, differentiation, and tissue development. Increasingly, epigenetic modifications are recognized for their involvement in various diseases, notably corneal disorders. Corneal fibrosis, a common consequence of ocular injury or infection, significantly contributes to visual impairment and blindness worldwide. Recent evidence indicates that epigenetic changes regulate key processes in corneal pathogenesis, such as inflammation, wound healing, extracellular matrix remodeling, fibrosis, and neovascularization. These findings underscore the potential of developing novel therapeutic strategies that specifically target epigenetic mechanisms to treat or mitigate corneal pathology. Nevertheless, bringing epigenetic therapies into clinical practice remains challenging given the complexity of epigenetic regulation. Future research leveraging multi-omics technologies and specific gene manipulation will be essential to elucidate the mechanisms underlying epigenetic regulation in corneal diseases and to identify specific therapeutic targets. Such advancements will drive the development of effective, clinically relevant treatments for corneal fibrosis and related disorders.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationbiomarkerscorneal fibrosisepigeneticshistone modificationnon-coding RNAstreatment

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15219, USA.
  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.

ORCID-Profile: Julia T Coelho, Moira L Geary, Mithun Santra

Förderung

  • NEI NIH HHS
  • Research to Prevent Blindness
  • Hillman Foundation
  • Eye and Ear Foundation of Pittsburgh
  • NIH RMIP
  • National Eye Institute

Zitieren

APA

Coelho, J. T., Dewald, E. J., Ali, S. R., Geary, M. L., Santra, M., & Yam, G. H. F. (2026). The Role of Epigenetics in Corneal Fibrosis. Epigenomes, 10(2), 40. https://doi.org/10.3390/epigenomes10020040

Vancouver

Coelho JT, Dewald EJ, Ali SR, Geary ML, Santra M, Yam GHF. The Role of Epigenetics in Corneal Fibrosis. Epigenomes. 2026;10(2):40. doi:10.3390/epigenomes10020040

BibTeX
@article{Coelho2026,
  author = {Coelho, Julia T and Dewald, Ella J and Ali, Syeda R and Geary, Moira L and Santra, Mithun and Yam, Gary H F},
  title = {The Role of Epigenetics in Corneal Fibrosis},
  journal = {Epigenomes},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {40},
  doi = {10.3390/epigenomes10020040}
}
Kostenlos starten →